Zobrazeno 1 - 10
of 35
pro vyhledávání: '"B. W. Sykes"'
Autor:
Bethanie Clark, Catherine Steel, Jessica Vokes, Jack R. Shan, Kristene Gedye, Amy Lovett, B. W. Sykes
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 37, Iss 4, Pp 1537-1543 (2023)
Abstract Background Rebound gastric hyperacidity (RGH) secondary to hypergastrinemia has been suggested to contribute to the rapid recurrence of equine squamous gastric disease (ESGD) in horses after discontinuation of omeprazole. Hypothesis/Objectiv
Externí odkaz:
https://doaj.org/article/72d333f475d4419fb394cb83915cbbca
Autor:
K. Niinistö, B. W. Sykes
Publikováno v:
Equine Veterinary Education. 34:600-606
Autor:
B. W. Sykes
Publikováno v:
Equine Veterinary Education. 33:556-560
Publikováno v:
Equine Veterinary Education. 32:71-81
In the horse, inappropriate management and training, as well as pain, frustration, fear and anxiety can result in undesirable behaviours. Common undesirable behaviours include pawing, striking, rearing, kicking, bolting, bucking, shying, napping, fre
Autor:
B. W. Sykes, H. Lambe
Publikováno v:
Equine Veterinary Education. 34
Autor:
B. W. Sykes
Publikováno v:
Equine Veterinary Education. 31:441-446
Oral omeprazole has been the cornerstone of equine gastric ulcer syndrome (EGUS) treatment for nearly 20 years. However, approximately 15-30% of equine squamous gastric disease (ESGD) cases and 75% of equine glandular gastric disease (EGGD) cases fai
Autor:
Rachael Conwell, B. W. Sykes, Mark Bowen, Tim Brazil, Michael Hewetson, David Rendle, Gayle D Hallowell, Richard Hepburn
Publikováno v:
UK-Vet Equine. 2:2-11
Foreword The European College of Equine Internal Medicine (ECEIM) consensus statement recently made the distinction between disease of the squamous mucosa (Equine Squamous Gastric Disease; ESGD) and of the glandular mucosa (Equine Glandular Gastric D
Autor:
B. W. Sykes, Krishna Kathawala, Stephen W. Page, Paul C. Mills, Yunmei Song, Sanjay Garg, C. Underwood
Publikováno v:
Equine Veterinary Journal. 49:795-801
Background: Pilot investigations have suggested that a novel, long-acting, injectable i.m. formulation of omeprazole (LA-OMEP) can induce acid suppression for up to 7 days following a single injection. Objectives: To investigate the pharmacodynamics
Publikováno v:
Equine Veterinary Journal. 49:637-642
Background: Esomeprazole warrants further investigation as a treatment for equine gastric ulcer syndrome. Objectives: To investigate the duration of intraday acid suppression achieved with two doses of esomeprazole under two dietary conditions. Study
Publikováno v:
Veterinary Medicine : Research and Reports
Emily K Cook,Nana Satake,Ben W Sykes,Emma L Bennett,Paul C Mills School of Veterinary Sciences, The University of Queensland, Gatton, Queensland, Australia Abstract: Investigation into the pharmacokinetic profile of esomeprazole was conducted using e